4//SEC Filing
Englese Thomas 4
Accession 0001415889-22-002868
CIK 0001708527other
Filed
Mar 9, 7:00 PM ET
Accepted
Mar 10, 8:46 PM ET
Size
16.5 KB
Accession
0001415889-22-002868
Insider Transaction Report
Form 4
Englese Thomas
Chief Commercial Officer
Transactions
- Award
Restricted Stock Units
2022-03-08+8,700→ 8,700 total→ Class A Common Stock (8,700 underlying) - Award
Restricted Stock Units
2022-03-08+15,390→ 15,390 total→ Class A Common Stock (15,390 underlying) - Sale
Class A Common Stock
2022-03-10−276→ 6,607 total - Award
Stock Option (Right to Buy)
2022-03-08+31,000→ 31,000 totalExercise: $5.08Exp: 2032-03-08→ Class A Common Stock (31,000 underlying) - Exercise/Conversion
Class A Common Stock
2022-03-08+938→ 6,883 total - Exercise/Conversion
Restricted Stock Units
2022-03-08−938→ 2,812 total→ Class A Common Stock (938 underlying)
Footnotes (8)
- [F1]Restricted stock units convert into shares of Class A Common Stock on a one-for-one basis.
- [F2]Includes 857 shares of Class A Common Stock acquired under the Company's 2020 Employee Stock Purchase Plan.
- [F3]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.16 to $5.34. The Reporting Person undertakes to provide Aziyo Biologics, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
- [F4]The option vests as to 25% of the shares on March 8, 2023 and in 12 equal quarterly installments thereafter, such that the option shall be fully vested and exercisable on March 8, 2026.
- [F5]Each restricted stock unit represents a contingent right to receive one share of Issuer Class A Common Stock.
- [F6]The restricted stock units vest if the Issuer's Class A Common Stock achieves a price per share equal to or greater than $10.00 for any period of thirty (30) consecutive trading days prior to March 8, 2024.
- [F7]On March 8, 2021, the Reporting Person was granted 3,750 restricted stock units, vesting in four substantially equal annual installments beginning in March 8, 2022.
- [F8]The restricted stock units vest on September 8, 2022, subject to the Reporting Person's continuous employment with the Issuer through such vesting date.
Documents
Issuer
AZIYO BIOLOGICS, INC.
CIK 0001708527
Entity typeother
Related Parties
1- filerCIK 0001825799
Filing Metadata
- Form type
- 4
- Filed
- Mar 9, 7:00 PM ET
- Accepted
- Mar 10, 8:46 PM ET
- Size
- 16.5 KB